PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23042933-9	2012	Further characterization using proteolytic footprinting experiments indicated that nelfinavir inhibited HSP90 in breast cancer cells through a novel mechanism.	Nelfinavir	83-93	heat shock protein 90 alpha family class A member 1	Homo sapiens	104-109	
24483157-3	2014	HSP90 is a molecular target for the HIV protease inhibitor nelfinavir (NFV).	Nelfinavir	59-69	heat shock protein 90 alpha family class A member 1	Homo sapiens	0-5	
23042933-12	2012	CONCLUSION: Nelfinavir was found to be a new class of HSP90 inhibitor and can be brought to HER2-breast cancer treatment trials with the same dosage regimen as that used among HIV patients.	Nelfinavir	12-22	heat shock protein 90 alpha family class A member 1	Homo sapiens	54-59